Friday, 15 June 2012

Informations of Deflazacort


Welcome To Plenus Pharmaceuticals (P) Ltd 
Informations of Deflazacort

 Plenus Pharmaceuticals is built on its meaning of completeness in pharmaceutical field through our quality healthcare service that leads to healthy life everywhere. It is complete healthcare in every aspect where there is no compromise with quality of products, ensuring full satisfaction to concerned entities.

Deflazacort is a prodrug. Its potency is around 70–90% that of prednisone. Steroids form an important component of dermatological therapy and are used since very long time for different conditions in different forms. Though very few molecules are used since very long time, the side effect associated with this group of drugs are almost always there. Recently a new molecule deflazacort has been introduced into Indian market, is a glucocorticoid and a derivative of old molecule prednisolone. Deflazacort is a glucocorticoid. Its anti-inflammatory and immunosuppressive effects are used in treating various diseases and are comparable to other anti-inflammatory steroids. Clinical studies have indicated that the average potency ratio of deflazacort to prednisolone is 0.69-0.89 and 6 mg of deflazacort is equivalent to 5 mg of prednisolone.

Deflazacort is a glucocorticoid derived from prednisolone and 6 mg of deflazacort it has approximately the same anti-inflammatory potency as 5 mg prednisolone or prednisone. Doses vary widely in different diseases and different patients. In more serious and life-threatening conditions, high doses of deflazacort may need to be given. When deflazacort is used for long term in relatively benign chronic diseases, the maintenance dose should be kept as low as possible. Dosage may need to be increased during periods of stress or during exacerbation of illness. The dosage should be individually titrated according to diagnosis, severity of disease and patient response and tolerance. The lowest dose that will produce an acceptable response should be used. The dose of deflazacort should be carefully monitored and adjusted to the minimum effective dose.


Keywords

Contact Us-

Plenus Pharmaceuticals Private Limited
PLENUS BUILDING
SHIV VIHAR, NEAR LAL MANDIR,
ARYA NAGAR JWALAPUR,
HARIDWAR. (U.K.) 249407
Mobile: 09737475726








No comments:

Post a Comment